Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells

International Journal of Cancer

Volumn 75, Issue 4, 1998, Pages 590-595

  White, Cathrine A ^a   Thomson, Scott A ^a   Cooper, Leanne ^a   Van Endert, Peter M ^b   Tampe, Robert ^c   Coupar, Barbara ^d   Qiu, Li ^a   Parsons, Peter G ^a   Moss, Denis J ^a   Khanna, Rajiv ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA CELL; PRIORITY JOURNAL; TUMOR IMMUNITY;

ANTIGEN-PRESENTING CELLS; ATP-BINDING CASSETTE TRANSPORTERS; CYTOTOXICITY, IMMUNOLOGIC; EXTRACELLULAR MATRIX PROTEINS; GENES, MHC CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE II; MELANOMA; NERVE TISSUE PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; VACCINIA VIRUS;

EID: 0032498555     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980209)75:4<590::AID-IJC16>3.0.CO;2-D     Document Type: Article

References (31)

1. ANICHINI, A., FOSSATI, G. and PARMIANI, G., Heterogeneity of clones from a human metastatic melanoma detected by autologous eytotoxic T lymphocyte clones. J. exp. Med., 163, 215-220 (1986).
2. BOYLE, D.B., COUPAR, B.E.H. and BOTH, G.W., Multiple-cloning-site plasmids for the rapid construction of recombinant poxviruses. Gene, 35, 169-177 (1985).
3. BURROWS, S.R., GARDNER, J., KHANNA, R., STEWARD, T., Moss, D.J., RODDA, S. and SHURBIER, A., Five new eytotoxic T Cell epitopes identified within Epstein-Barr virus nuclear antigen 3. J. gen. Virol., 75, 2489-2493 (1994).
4. BORROWS, S.R., RODDA, S.J., SUHRBIER, A., GEYSEN, H.M. and Moss, D.J., The specificity of recognition of a cytotoxic T lymphocyte epitope. Europ. J. Immunol., 22, 191-195 (1992).
5. CHEN, L., ASHE, S., BRADY, W.A., HELLSTRöM, I., HELLSTRÖM, K.E., LEDBETTER, J.A., MCGOWAN, P. and LINSLEY, P.S., Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell. 71, 1093-1099 (1992).
6. ELLIOTT, B.E., CARLOW, D.A., RODRICKS, A.M. and WADE, A., Perspectives on the role of MHC antigens in normal and malignant cell development. Adv. Cancer Res., 53, 181-245 (1989).
7. FEARON, E.R., PARDOLL, D.M., ITAYA, T., GOLUMBEK, P., LEVITSKY, H.I., SIMONS, J.W., KARASUYAMA, H., VUGELSTEIN, B. and FROST, P., Interleukin-2 production by tumor cells bypasses helper T cell function in the generation of an antitumor response. Cell, 60, 397-403 (1990).
8. GREENBERG, P.D., Adoptive T cell therapy of tumors: mechanisms operative in the recognition of elimination of tumor cells. Adv. Immunol., 49, 281-355 (1991).
9. HOUGHTON, A.N., EISISGER, M., ALBINO, A.P., CAIRNCROSS, J.C. and OLD, L.J., Surface antigens of melanocytes and melanomas. Markers of melanocytes differentiation and melanoma subsets. J. exp. Med, 156, 1755-1766 (1982).
10. KHANNA, R., BURROWS, S.R., ARGAET, V. and Moss, D.J., Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line. Int. Immunol. 6, 639-645 (1994).
11. KHANNA, R., BORROWS, S.R., KURILLA, M.G., JACOB, C.A., MISKO, I.S., SCULLEY, T.B., KIEFF, E. and Moss, D.J., Localization of Epstein-Barr virus cytotoxic T-cell epitopes using recombinant vaccinia: implications for vaccine development. J. exp. Med., 176, 169-176 (1992).
12. KHANNA, R., BURROWS, S.R., SHURBIER, A., JACOB, C., GRIFFIN, H., MISKO, I.S., SCULLEY, T.B., ROWE, M., RICKINSON, A.B. and Moss. D.J., EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2. J. Immunol., 150, 5154-5162 (1993a).
13. KHANNA, R., JACOB, C.A., BURROWS, S.R., KURILLA, M.G., KIEFF, E., MISKO, I.S. and Moss, D.J., Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T-cells. Immunology, 74, 504-510 (1991).
14. KHANNA, R., JACOB, C.A., BURROWS, S.R. and Moss, D.J., Presentation of endogenous viral peptide epitopes by anti-CD40 stimulated human B cells following recombinant vaccinia infection. J. Immunol. Methods, 164, 41-49 (1993b).
15. LOBIGS, M. and MULLBACHER, A., Recombinant expression of vaccinia virus-encoded TAP1 and TAP2 promotes MHC class I-restricted antigen presentation in a Syrian hamster cell line. Immunol. cell. Biol., 73, 181-184 (1995).
16. --phenotype. Cancer Res., 46, 5009-5013 (1986).
17. MELIEF, C.J., Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res., 58, 143-175 (1992).
18. MEYER, T.H., VAN ENDERT, P.M., UEBEL, S., EHRING, B. and TAMPE, R., Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Lett., 351, 443-447 (1994).
19. MISKO, I.S., SOSZYNSKI, T.D., KANE, R.G. and POPE, J.H., Factors influencing the human cytotoxic T cell response to autologous lymphoblastoid cell lines in vitro. Clin. Immunol. Immunopathol., 32, 285-297 (1984).
20. MONACO, J.J., CHO, S. and ATTAYA, M., Transport protein genes in the murine MHC: possible implications for antigen processing. Science. 250, 1723-1726 (1990).
21. PRUSS, R.M., MIRSKY, R., RAFF, M.C., THORHU, R., DOWLING, A.J. and ANDERTON, B.H., All classes of intermediate filaments share a common antigenic determinant defined by a monoclonal antibody. Cell, 3, 419-428 (1981).
22. RESTIFO, N.P., ESQUWEL, p., K.AWAKAMI, Y. YEWDELL, J.W., MULE, J.J., ROSENBERG, S.A. and BENNINK, J.R., Identification of human cancers deficient in antigen processing. J. exp. Med., 177, 265-272 (1993).
23. ROSENBERG, S.A., GRIMM, E.A., MCGROGAN, M., DOYLE, M., KAWASAKI, E., KOTHS, K. and MARK, D.F., Biological activity of recombinant human interleukin-2 produced in Escherichia coli Science, 223, 1412-1414 (1984).
24. SPIES, T., BRESNASHAN, M., BAHRAM, S., ARNOLD, D., BLANCK, G., MELLINS, E., PIOUS, D. and DEMARS, R., A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature (Lond.), 348, 744-747 (1990).
25. THOMSON, J.A.F., PARSONS, P.C. and STURM, R.A., In vivo and in vitro expression of octamer binding proteins in human melanoma metastases, brain tissue and fibroblasts. Pigment Cell Res., 6, 13-22 (1993).
26. TODARO, G.J., FRYLINU, C. and DE LARCO, J.E., Transforming growth factors produced by certain tumor cells: polypeptides that interact with epidermal growth factor receptor. Proc. nat. Acad. Sci. (Wash.), 77, 5258-5262 (1980).
27. 8+ T cells by B7-transfected melanoma cells. Science, 259, 368-370 (1993).
28. VAN ENDERT, P.M., TAMPE, R., MEYER, T.H., TISCH, R., BACH, J.F. and MCDEVITT, H.O., A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity, 6, 491-500 (1994).
29. WANG, A., LU, S.D. and MARK, D.F., Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. Science, 224, 1431-1433 (1984).
30. WHITEHEAD, R. and LITTLE, J.H., Tissue culture studies on human malignant melanoma. Pigment Cell, 1, 382-389 (1973).
31. YEWDELL, J.W. and BENNINK, J.R., Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol., 25, 1-123 (1992).